RxDoctor Payments Data

Rosa Casillas

Adult Health · Kennewick, WANPI 1831831262

Payments from drug & device makers

$826in general payments, 2019–2025

Across 41 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$184
  • Amgen$181
  • AstraZeneca$82
  • UCB, Inc.$54
  • Organon$54
  • E.r. Squibb & Sons, L.L.C.$52
  • plus $219 from 8 others

What the payments were for

  • Food & beverage$826100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$826 in reported general payments places this provider in the 75th percentile of 252 adult health providers in Washington.

See all adult health providers in Washington

Medicare billing

Part B allowed, 2024
$67,093
Medicare patients
432
Services billed
1,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab51$456,023
Enbrel SureclickEtanercept44$366,096
Humira PenAdalimumab33$247,427
Xeljanz XrTofacitinib Citrate39$237,607
RinvoqUpadacitinib21$184,273
OtezlaApremilast27$139,979
Humira(Cf)Adalimumab15$135,373
Taltz AutoinjectorIxekizumab19$135,136
Cimzia (2 Pack)Certolizumab Pegol17$99,489
OrenciaAbatacept11$57,105
Hydroxychloroquine Sulfate343$16,571
MethotrexateMethotrexate Sodium411$12,008
Leflunomide147$6,095
Sulfasalazine70$2,911
Cevimeline Hcl21$2,043

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Humira(Cf)$184$319,64636 claims
AmgenOtezla$181$139,97927 claims
UCB, Inc.Cimzia (2 Pack)$54$99,48917 claims
E.r. Squibb & Sons, L.L.C.Orencia$52$57,10511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 252 adult health providers in Washington.

Other adult health in Kennewick

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →